Lung Cancer Screening Knowledge Among Internal Medicine Residents in a University Program.
Early detection of cancer
Graduate medical education
Lung neoplasm
Lung screening knowledge
Journal
Journal of cancer education : the official journal of the American Association for Cancer Education
ISSN: 1543-0154
Titre abrégé: J Cancer Educ
Pays: England
ID NLM: 8610343
Informations de publication
Date de publication:
12 2021
12 2021
Historique:
pubmed:
21
4
2020
medline:
29
1
2022
entrez:
21
4
2020
Statut:
ppublish
Résumé
Lung cancer remains the main cause of cancer-related death. Even though several societies recommend that certain populations may benefit from lung cancer screening with low-dose computed tomography (LDCT), its nationwide adoption has been slow. Practices in primary care are closely linked to residency training. Recognizing gaps in knowledge during training may translate into increased utilization of life-saving measures. Sixty internal medicine residents training at a university-based program were presented with an anonymous online-based survey designed to measure their knowledge about lung cancer screening. In the second phase, residents were presented with an infographic containing the answers to the initial survey. They were surveyed again 30 days after this intervention. The average correct response rate among all years was 42%. PGY-1 residents performed better compared with PGY-2 and PGY-3 residents (p = 0.015). Ninety-two percent of residents did not think screening improved all-cause mortality. Less than half thought screening had a lung cancer-specific mortality benefit. Fifty-three percent rated their self-perceived knowledge above 50%. There was no difference in knowledge after the intervention. Specific populations may benefit from LDCT screening. Even if these benefits do not directly translate to population settings, the burden and mortality of lung cancer calls for urgent measures to attempt an earlier diagnosis. Internal medicine residents in this program may have several concerns about lung cancer screening including coverage, benefit, and false positive rate. Educational methods such as infographics may not be effective in improving knowledge among residents. Lung cancer screening should be a priority in medical education, especially in states with high smoking rates and lung cancer mortality.
Identifiants
pubmed: 32307666
doi: 10.1007/s13187-020-01747-9
pii: 10.1007/s13187-020-01747-9
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1186-1192Informations de copyright
© 2020. American Association for Cancer Education.
Références
Ferlay J, Shin H-R, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127(12):2893–2917. https://doi.org/10.1002/ijc.25516
doi: 10.1002/ijc.25516
pubmed: 21351269
Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R et al (2007) The IASLC lung cancer staging project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2(8):706–714. https://doi.org/10.1097/JTO.0b013e31812f3c1a
doi: 10.1097/JTO.0b013e31812f3c1a
pubmed: 17762336
IASLC > International Association for the Study of Lung Cancer > About IASLC > News Detail. (n.d.). Retrieved December 31, 2019, from https://www.iaslc.org/About-IASLC/News-Detail/iaslc-issues-statement-on-lung-cancer-screening-with-low-dose-computed-tomography
Schwartz, L. M., Woloshin, S., Fowler, F. J., & Welch, H. G. (n.d.). Enthusiasm for Cancer Screening in the United States 8
Klabunde CN, Frame PS, Meadow A, Jones E, Nadel M, Vernon SW (2003) A national survey of primary care physicians’ colorectal cancer screening recommendations and practices. Prev Med 36(3):352–362. https://doi.org/10.1016/S0091-7435(02)00066-X
doi: 10.1016/S0091-7435(02)00066-X
pubmed: 12634026
Şahin MK, Aker S (2017) Family physicians’ knowledge, attitudes, and practices toward colorectal Cancer screening. J Cancer Educ 32(4):908–913. https://doi.org/10.1007/s13187-016-1047-9
doi: 10.1007/s13187-016-1047-9
pubmed: 27193411
Roth JA, Carter-Harris L, Brandzel S, Buist DSM, Wernli KJ (2018) A qualitative study exploring patient motivations for screening for lung cancer. PLoS One 13(7):e0196758. https://doi.org/10.1371/journal.pone.0196758
doi: 10.1371/journal.pone.0196758
pubmed: 29975709
pmcid: 6033377
Lewis JA, Petty WJ, Tooze JA, Miller DP, Chiles C, Miller AA, Bellinger C, Weaver KE (2015) Low-dose CT lung cancer screening practices and attitudes among primary care providers at an Academic Medical Center. Cancer Epidemiol Biomark Prev 24(4):664–670. https://doi.org/10.1158/1055-9965.EPI-14-1241
doi: 10.1158/1055-9965.EPI-14-1241
Ersek JL, Eberth JM, McDonnell KK, Strayer SM, Sercy E, Cartmell KB, Friedman DB (2016) Knowledge of, attitudes toward, and use of low-dose computed tomography for lung cancer screening among family physicians: LDCT for lung cancer screening. Cancer 122(15):2324–2331. https://doi.org/10.1002/cncr.29944
doi: 10.1002/cncr.29944
pubmed: 27294476
Eberth JM, Bozorgi P, Lebrón LM, Bills SE, Hazlett LJ, Carlos RC, King JC (2018) Geographic availability of low-dose computed tomography for lung cancer screening in the United States, 2017. Prev Chronic Dis 15:180241. https://doi.org/10.5888/pcd15.180241
doi: 10.5888/pcd15.180241
Centers for Disease Control and Prevention. State Tobacco Activities Tracking and Evaluation (STATE) System. Available at: https://www.cdc.gov/statesystem
American Lung Association. (2019) Lung Cancer screening Coverage in State Medicaid Programs. Retrieved from: https://www.lung.org/assets/documents/lung-cancer/lung-cancer-screening-1.pdf
Petterson S, McNellis R, Klink K, Meyers D, Bazemore A. The state of primary care in the United States: a chartbook of facts and statistics. January 2018
Evidence Summary: Lung cancer: screening. U.S. Preventive Services Task Force. September 2016. https://www.uspreventiveservicestaskforce.org/Page/SupportingDoc/lung-cancer-screening/evidence-summary4
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, JG. (2009) Conde, research electronic data capture (REDCap) – a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42(2):377–381
doi: 10.1016/j.jbi.2008.08.010
Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O’Neal L, McLeod L, Delacqua G, Delacqua F, Kirby J, Duda SN, REDCap Consortium (2019) The REDCap consortium: Building an international community of software partners. J Biomed Inform. https://doi.org/10.1016/j.jbi.2019.103208
The National Lung Screening Trial Research Team (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365(5):395–409. https://doi.org/10.1056/NEJMoa1102873
doi: 10.1056/NEJMoa1102873
pmcid: 4356534
Richards TB, Doria-Rose VP, Soman A, Klabunde CN, Caraballo RS, Gray SC, Houston KA, White MC (2019) Lung cancer screening inconsistent with U.S. preventive services task force recommendations. Am J Prev Med 56(1):66–73. https://doi.org/10.1016/j.amepre.2018.07.030
doi: 10.1016/j.amepre.2018.07.030
pubmed: 30467092
Zahnd WE, Eberth JM (2019) Lung cancer screening utilization: a behavioral risk factor surveillance system analysis. Am J Prev Med 57(2):250–255. https://doi.org/10.1016/j.amepre.2019.03.015
doi: 10.1016/j.amepre.2019.03.015
pubmed: 31248742
Jaklitsch MT, Jacobson FL, Austin JHM, Field JK, Jett JR, Keshavjee S, MacMahon H, Mulshine JL, Munden RF, Salgia R, Strauss GM, Swanson SJ, Travis WD, Sugarbaker DJ (2012) The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. J Thorac Cardiovasc Surg 144(1):33–38. https://doi.org/10.1016/j.jtcvs.2012.05.060
doi: 10.1016/j.jtcvs.2012.05.060
pubmed: 22710039
CMS. (2016) Decision memo for screening for lung cancer with low dose computed tomography (LDCT) (CAG-00439N). 71. Retrieved from: https://www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?NCAId=274
De Koning H, Van Der Aalst C, Ten Haaf K, Oudkerk M (2018) PL02.05 effects of volume CT lung cancer screening: mortality results of the NELSON randomised-controlled population based trial. J Thorac Oncol 13(10):S185. https://doi.org/10.1016/j.jtho.2018.08.012
doi: 10.1016/j.jtho.2018.08.012
Pastorino U, Silva M, Sestini S, Sabia F, Boeri M, Cantarutti A, Sverzellati N, Sozzi G, Corrao G, Marchianò A (2019) Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy. Ann Oncol 30(7):1162–1169. https://doi.org/10.1093/annonc/mdz117
doi: 10.1093/annonc/mdz117
pubmed: 30937431
pmcid: 6637372
Becker, N., Motsch, E., Trotter, A., Heussel, C. P., Dienemann, H., Schnabel, P. A., Kauczor, H., Maldonado, S. G., Miller, A. B., Kaaks, R., & Delorme, S. (2019). Lung cancer mortality reduction by LDCT screening—results from the randomized German LUSI trial. International Journal of Cancer, ijc.32486. https://doi.org/10.1002/ijc.32486
Saquib N, Saquib J, Ioannidis JP (2015) Does screening for disease save lives in asymptomatic adults? Systematic review of meta-analyses and randomized trials. Int J Epidemiol 44(1):264–277. https://doi.org/10.1093/ije/dyu140
doi: 10.1093/ije/dyu140
pubmed: 25596211
Penston J (2011) Should we use total mortality rather than cancer specific mortality to judge cancer screening programmes? 2. Br Med J 343:938–9390. https://doi.org/10.1136/bmj.d6395
doi: 10.1136/bmj.d6395
Heijnsdijk EAM, Csanádi M, Gini A, Haaf K, Bendes R, Anttila A, Senore C, de Koning HJ (2019) All-cause mortality versus cancer-specific mortality as outcome in cancer screening trials: a review and modeling study. Cancer Medicine 8(13):6127–6138. https://doi.org/10.1002/cam4.2476
doi: 10.1002/cam4.2476
pubmed: 31422585
pmcid: 6792501
Pinsky PF, Church TR, Izmirlian G, Kramer BS (2013) The National Lung Screening Trial: results stratified by demographics, smoking history, and lung cancer histology: National Lung Screening Trial. Cancer 119(22):3976–3983. https://doi.org/10.1002/cncr.28326
doi: 10.1002/cncr.28326
pubmed: 24037918
Caverly TJ, Fagerlin A, Wiener RS, Slatore CG, Tanner NT, Yun S, Hayward R (2018) Comparison of observed harms and expected mortality benefit for persons in the veterans health affairs lung cancer screening demonstration project. JAMA Intern Med 178(3):426–428. https://doi.org/10.1001/jamainternmed.2017.8170
doi: 10.1001/jamainternmed.2017.8170
pubmed: 29356812
pmcid: 5885917
Grol R, Wensing M (2004) What drives change? Barriers to and incentives for achieving evidence-based practice. Med J Aust 180(S6). https://doi.org/10.5694/j.1326-5377.2004.tb05948.x
Grol R, Grimshaw J (2003) From best evidence to best practice: effective implementation of change in patients’ care. Lancet 362(9391):1225–1230. https://doi.org/10.1016/S0140-6736(03)14546-1
doi: 10.1016/S0140-6736(03)14546-1
pubmed: 14568747
Tufte ER (2001) The visual display of quantitative information, vol 2. Graphics press, Cheshire, CT
Alshehri MA, Ebaid M (2016) The effectiveness of using interactive infographic at teaching mathematics in elementary school. British Journal of Education 4(3):1–8
Wedel M, Pieters R (2008) Eye tracking for visual marketing. Foundations and Trends® in Marketing 1(4):231–320
doi: 10.1561/1700000011
Buljan I, Malički M, Wager E, Puljak L, Hren D, Kellie F, West H, Alfirević Ž, Marušić A (2018) No difference in knowledge obtained from infographic or plain language summary of a Cochrane systematic review: three randomized controlled trials. J Clin Epidemiol 97:86–94. https://doi.org/10.1016/j.jclinepi.2017.12.003
doi: 10.1016/j.jclinepi.2017.12.003
pubmed: 29269021